124I-M5A

N/A

Report date: 2025/10/20 14:38:49
NME

Base Information

Drug Name124I-M5A
Drug Alias NameIodine I 124 Monoclonal Antibody M5AIodine I 124 Anti-CEA Monoclonal Antibody M5A
ClassificationRadiation-emitting products > Nuclides > Iodine > 124IRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionAnti-CEACAM5
TargetsCarcinoembryonic antigen related cell adhesion molecule 5
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCity Of Hope National Medical CenterNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesNational Cancer InstituteCity Of Hope National Medical Center
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A